Medartis Holding AG

SWX:MED Stock Report

Market Cap: CHF 1.1b

Medartis Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MED?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms778,3376.27%
Institutions850,1206.85%
Private Companies921,0357.42%
Hedge Funds1,358,64310.9%
General Public2,178,53217.5%
Individual Insiders6,331,71851%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
45.3%
Thomas Straumann
5,624,430CHF 489.3m0%no data
10.9%
Nordflint Capital Partners Fondsmaeglerselskab A/S
1,358,643CHF 118.2m-14.3%21.95%
7.42%
NexMed Holding AG
921,035CHF 80.1m0%no data
6.27%
Endeavour Vision SA
778,337CHF 67.7m0%73.04%
4.98%
Willi Miesch
617,917CHF 53.8m0%no data
1.45%
The Vanguard Group, Inc.
179,692CHF 15.6m0.05%no data
1.37%
UBS Asset Management AG
170,065CHF 14.8m0%no data
1.03%
Vontobel Asset Management AG
128,316CHF 11.2m0%0.06%
0.51%
Deka Investment GmbH
63,821CHF 5.6m0%0.01%
0.48%
Entrepreneur Partners AG
60,000CHF 5.2m0%1.05%
0.47%
BlackRock, Inc.
58,574CHF 5.1m-2.06%no data
0.35%
Pax Asset Management AG
43,000CHF 3.7m0%0.38%
0.3%
Christoph Bronnimann
36,699CHF 3.2m0%no data
0.29%
ZKB Asset Management
35,494CHF 3.1m0%0.01%
0.2%
Damien Tappy
25,365CHF 2.2m0%no data
0.16%
Bruellan SA
20,000CHF 1.7m0%0.62%
0.15%
Zürcher Kantonalbank
19,064CHF 1.7m0%0.01%
0.12%
Vontobel Asset Management SA
14,494CHF 1.3m0%0.02%
0.082%
Norges Bank Investment Management
10,146CHF 882.7k-77.8%no data
0.071%
Rieter Fischer Partners
8,878CHF 772.4k0%0.46%
0.071%
Marco Gadola
8,841CHF 769.1k0%no data
0.071%
Basler Kantonalbank
8,800CHF 765.6k0%0.05%
0.066%
Charles Schwab Investment Management, Inc.
8,151CHF 709.2k0.26%no data
0.059%
Mareike Loch
7,265CHF 632.0k0%no data
0.038%
Amundi Asset Management SAS
4,765CHF 414.5k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/01 17:31
End of Day Share Price 2025/10/01 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Medartis Holding AG is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christoph GretlerCredit Suisse
Arsene GuekamKepler Cheuvreux
Alexander BurganskyResearch Partners AG